Log in to save to my catalogue

Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache

Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2622667643

Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache

About this item

Full title

Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache

Publisher

Cham: Springer International Publishing

Journal title

Neurological sciences, 2022-02, Vol.43 (2), p.1273-1280

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Objective
To determine whether erenumab is effective and safe in refractory chronic migraine with medication overuse headache.
Methods
In this prospective, multicentric, real-life study, chronic migraine with medication overuse headache patients who received erenumab were recruited. Study inclusion was limited to patients who previously fa...

Alternative Titles

Full title

Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2622667643

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2622667643

Other Identifiers

ISSN

1590-1874

E-ISSN

1590-3478

DOI

10.1007/s10072-021-05426-5

How to access this item